3 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 2 Phase 1, 2 Phase 3, 2 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 4 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Compound Danshen Dripping Pills: new trials by email Literature Review of Compound Danshen Dripping Pills trials Research Report on Compound Danshen Dripping Pills
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Coronary MicrovAscular Diseases Intervention With Compound Danshen Dropping Pills Compound Danshen Dripping Pills, Placebo - Coronary Microvascular Disease | Phase 4 | Not yet recruiting | Qilu Hospital of Shandong University | 496 | 2026-10-01 | 2026-10-21 |
| Pre-trial of Clinical Trial of Traditional Chinese Medicine Treatment for Elderly Patients With Coronary Heart Disease Who Are Still Symptomatic After Optimal Medical Treatment Compound Danshen Dripping Pills, Qishen Yiqi Drop Pills, Placebo - Coronary Arterial Disease (CAD) | Phase 4 | Recruiting | China National Center for Cardiovascular Diseases | 120 | 2025-08-18 | 2025-09-29 |
| Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness Placebo, Compound danshen dripping pills - Acute Mountain Sickness | Phase 1 / Phase 2 | Completed | Tasly Pharmaceuticals, Inc. | 58 | 2016-06-24 | 2017-09-01 |
| Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy Compound danshen dripping pills, Placebo - Non-proliferative Diabetic Retinopathy | Phase 3 | Unknown | Tasly Pharmaceuticals, Inc. | 480 | 2013-05-01 | 2017-03-21 |
| Dose-Escalate Study to Investigate the Safety and Tolerability of T89 in Japanese T89 Group A, Placebo Group A, Placebo Group B - Healthy | Phase 1 | Completed | Tasly Pharmaceuticals, Inc. | 20 | 2012-08-01 | 2014-11-24 |
| Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina T89 high dose, T89 Low dose, Sanqi+Bingpian - Angina Pectoris | Phase 3 | Completed | Tasly Pharmaceuticals, Inc. | 1004 | 2012-08-01 | 2017-03-09 |
Altitude Sickness (1) · Angina Pectoris (1) · Microvascular Angina (1)
Tasly Pharmaceuticals, Inc. (4) · China National Center for Cardiovascular Diseases (1) · Qilu Hospital of Shandong University (1)
China (4) · United States (2) · Belarus (1) · Canada (1) · Georgia (1) · Mexico (1) · Russia (1) · Ukraine (1)
Min Zhao, PhD (2) · Henry He Sun, PhD (1) · Yun Zhang, MD,PhD (1)